Proteomic Analysis of Prostate Cancer FFPE Samples Reveals Markers of Disease Progression and Aggressiveness

Proteomic Analysis of Prostate Cancer FFPE Samples Reveals Markers of Disease Progression and Aggressiveness

Prostate cancer (PCa) is the second most common cancer in men. Diagnosis and risk assessment are widely based on serum Prostate Specific Antigen (PSA) and biopsy, which might not represent the exact degree of PCa risk. Towards the discovery of biomarkers for better patient stratification, we perform...

Full description

Bibliographic Details
Main Authors: Vasiliki Lygirou, Konstantinos Fasoulakis, Rafael Stroggilos, Manousos Makridakis, Agnieszka Latosinska, Maria Frantzi, Ioannis Katafigiotis, Christos Alamanis, Konstantinos G. Stravodimos, Constantinos A. Constantinides, Antonia Vlahou, Jerome Zoidakis
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Cancers
Subjects:
prostate cancer
proteomics
biochemical recurrence
biomarkers
FFPE samples
geLC-MS/MS
Online Access:https://www.mdpi.com/2072-6694/14/15/3765

Internet

https://www.mdpi.com/2072-6694/14/15/3765

Similar Items